Last edition
News about
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Dimensionless Technologies Revolutionizes Pharma Sector Supply Chain with AushadhAI
Dimensionless Technologies Revolutionizes Pharma Sector Supply Chain with AushadhAI
Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Sigachi Industries Limited Forays Into API Business With Strategic Majority Stake In Trimax Bio Sciences
Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 19.01 crore in Q1FY24, growth of 26.66% Y-o-Y
Hikal Limited Shows Resilient Performance Amid Industry Headwinds
Hikal’s Panolisite undergone US FDA audit which was concluded with ‘Zero’ 483 observations. US FDA approval is in line with de-risking strategy for additional API site to service our global customer base.
Granules India Q1FY24 Revenue from Operations at INR 9855 mn down 3 Percent YoY
ROCE stood at 9.4 percent and net debt stood at INR 8,569 mn
IOL Chemicals and Pharmaceuticals Net Profit Grows 32 Percent YoY
The total income for Q1 FY24 stood at INR 570 crore at the same level of INR 570 crore YoY. EBITDA for Q1 FY24 was INR 80 crore as compared to INR 61 crore YoY.
MedPlus looks to set up own pharma manufacturing units
MedPlus looks to set up own pharma manufacturing units
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy